We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Quick reference materials for primary care on diagnosing and understanding culture results for urinary tract infections (UTI).
Strategic behavioural analysis that aims to help understand and change behaviours related to catheter-associated urinary tract infections.
This strategic behavioural analysis aims to help understand and change behaviours related to preventing catheter-associated urinary tract infections (CAUTI).
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
We’re seeking views on updating the diagnosis of urinary tract infections (UTIs) quick reference guide for primary care providers.
The characteristics, diagnosis, management, surveillance and epidemiology of Escherichia coli (E. coli).
Employers guide to assessing fitness to work, including asking for medical evidence, fit notes, and dealing with long term or frequent absences.
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
Healthcare professionals prescribing nitrofurantoin should be alert to the risks of pulmonary and hepatic adverse drug reactions and advise patients to be vigilant for the signs and symptoms in need of further investigation.
The diagnosis, management and surveillance of extended-spectrum beta-lactamases (ESBLs).
The Brucella Reference Unit (BRU) provides laboratory diagnostic and clinical management services for Brucella species.
The diagnosis and surveillance of Acinetobacter spp. bacteraemia.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
The characteristics, diagnosis, management, surveillance and epidemiology Enterococcus species and Glycopeptide Resistant Enterococci (GRE).
Projects granted during 2016 that have a primary purpose of translational research - human urogenital/reproductive disorders.
This is the council’s note about the occupational risks for urolithiasis (stones anywhere in the upper urinary tract, the bladder, the ureters or the kidneys).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.